PS
| |
PRENTISS SMITH & CO INC13F | |
| PRENTISS SMITH & CO INC | |
| Last update 2025-04-21 | 69 Stocks (4 new) |
| Value $154.00 Mil | Turnover 8 % |
PRENTISS SMITH & CO INC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSCO | Cisco Systems Inc | 143,481 | 8,854.2 | +0.16% | 5.740 | +0.01% | 0.000 | +22.77% | +17.21% | 269,477.9 | Hardware | |
GOOG | Alphabet Inc | 48,128 | 7,519.0 | -0.43% | 4.870 | -0.03% | 0.000 | +21.39% | -2.13% | 2,250,461.0 | Interactive Media | |
JNJ | Johnson & Johnson | 43,964 | 7,291.0 | -0.77% | 4.730 | -0.03% | 0.000 | +4.85% | +15.08% | 393,874.2 | Drug Manufacturers | |
ALC | Alcon Inc | 70,551 | 6,697.4 | -1.14% | 4.340 | -0.05% | 0.010 | -5.27% | +3.27% | 43,201.9 | Medical Devices & Instruments | |
GRC | Gorman-Rupp Co | 170,715 | 5,992.1 | 0% | 3.880 | 0% | 0.650 | +11.74% | -0.89% | 978.7 | Industrial Products | |
ABT | Abbott Laboratories | 44,965 | 5,964.6 | -21.91% | 3.870 | -0.93% | 0.000 | -5.16% | +10.91% | 215,165.7 | Medical Devices & Instruments | |
PG | Procter & Gamble Co | 32,335 | 5,510.5 | +14.70% | 3.570 | +0.46% | 0.000 | -7.91% | -5.70% | 363,638.5 | Consumer Packaged Goods | |
SCHW | Charles Schwab Corp | 69,983 | 5,478.3 | +23.58% | 3.550 | +0.68% | 0.000 | +26.21% | +30.29% | 174,065.8 | Capital Markets | |
NVS | Novartis AG | 47,892 | 5,339.0 | -0.95% | 3.460 | -0.03% | 0.000 | +3.06% | +21.78% | 222,482.5 | Drug Manufacturers | |
BDX | Becton Dickinson & Co | 22,724 | 5,205.2 | +0.19% | 3.370 | +0.01% | 0.010 | -9.45% | -20.33% | 51,259.7 | Medical Devices & Instruments |
PRENTISS SMITH & CO INC's Historical Top Holdings Breakdowns
PRENTISS SMITH & CO INC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
COO | The Cooper Companies Inc | 2025-03-31 | New Buy New Buy | +2.69% | 77.73 ($89.6) 99.45 | $72.63 | -18.94% | New holding | 49,204 | 49,204 | |
WMS | Advanced Drainage Systems Inc | 2025-03-31 | Add Add | +2.67% | 105.29 ($116.57) 126.99 | $111.75 | -4.13% | Add 553.32% | 44,759 | 37,908 | |
UL | Unilever PLC | 2025-03-31 | Sold Out Sold Out | -2.08% | 54.72 ($57.34) 60.29 | $59.70 | 4.12% | Sold Out | 0 | -56,066 | |
ABT | Abbott Laboratories | 2025-03-31 | Reduce Reduce | -0.93% | 111.1 ($127.27) 140.22 | $123.67 | -2.83% | Reduce -21.91% | 44,965 | -12,618 | |
AMAT | Applied Materials Inc | 2025-03-31 | New Buy New Buy | +0.72% | 145.06 ($168.16) 195.51 | $190.44 | 13.25% | New holding | 7,669 | 7,669 | |
SCHW | Charles Schwab Corp | 2025-03-31 | Add Add | +0.68% | 71.24 ($78.48) 83.64 | $95.80 | 22.07% | Add 23.58% | 69,983 | 13,353 | |
LNN | Lindsay Corp | 2025-03-31 | Sold Out Sold Out | -0.57% | 116.77 ($130.52) 139.05 | $137.18 | 5.10% | Sold Out | 0 | -7,378 | |
UBER | Uber Technologies Inc | 2025-03-31 | New Buy New Buy | +0.56% | 63.17 ($72.04) 81.49 | $90.59 | 25.75% | New holding | 11,787 | 11,787 | |
PG | Procter & Gamble Co | 2025-03-31 | Add Add | +0.46% | 158.56 ($167.49) 176.26 | $155.10 | -7.40% | Add 14.7% | 32,335 | 4,144 | |
NBIX | Neurocrine Biosciences Inc | 2025-03-31 | Sold Out Sold Out | -0.43% | 107.22 ($126.68) 153.29 | $132.02 | 4.22% | Sold Out | 0 | -4,763 |
PRENTISS SMITH & CO INC Total Holding History ($B)
PRENTISS SMITH & CO INC's Asset Allocation
PRENTISS SMITH & CO INC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
PRENTISS SMITH & CO INC's Hypothetical Growth since 2025-03-31
PRENTISS SMITH & CO INC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
PRENTISS SMITH & CO INC's Holdings Heat Map
Size field:
PRENTISS SMITH & CO INC's Holdings Bubble Chart
PRENTISS SMITH & CO INC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers